Xvivo Perfusion Logo

Xvivo Perfusion

Develops ex-vivo machine perfusion systems to improve organ viability for transplantation.

XVIVO | ST

Overview

Corporate Details

ISIN(s):
SE0004840718 (+1 more)
LEI:
549300G2464FYLS14B41
Country:
Sweden
Address:
Gemenskapens Gata 9, 431 53 Mölndal
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Xvivo Perfusion is a medical technology company specializing in solutions for ex-vivo organ preservation. The company develops and markets innovative systems, solutions, and services that enable clinicians and researchers to preserve, assess, and transport donated organs—including lungs, hearts, livers, and kidneys—outside the body prior to transplantation. Its core offering is centered on machine perfusion technology, which aims to increase the availability and improve the quality of viable organs. Key products include the XPS™ (Ex Vivo Lung Perfusion System), Liver Assist™, and Kidney Assist Transport™, as well as the PERFADEX® Plus preservation solution. Xvivo's technologies are designed to extend organ preservation time, enhance assessment, and ultimately improve transplant outcomes, addressing the global shortage of transplantable organs.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-08 10:01
Major Shareholding Notification
Swedish 9.5 KB
2025-07-28 22:10
Legal Proceedings Report
Fördröjning i CE-godkännandeprocessen för XVIVOs perfusionslösning för hjärtpre…
Swedish 64.3 KB
2025-07-28 22:10
Legal Proceedings Report
Delay in CE approval for XVIVO’s perfusion solution for heart preservation
English 63.6 KB
2025-07-11 07:30
Interim Report
Swedish 2.0 MB
2025-07-11 07:30
Interim Report
English 2.0 MB
2025-04-25 14:25
Post-Annual General Meeting Information
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
Swedish 59.6 KB
2025-04-25 14:25
Post-Annual General Meeting Information
Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)
English 60.1 KB
2025-04-24 07:30
Quarterly Report
Swedish 1.9 MB
2025-04-24 07:30
Interim Report
English 6.8 MB
2025-03-20 17:45
Pre-Annual General Meeting Information
Notice to attend the annual general meeting in XVIVO Perfusion AB (publ)
English 111.0 KB
2025-03-20 17:45
Pre-Annual General Meeting Information
Kallelse till årsstämma i XVIVO Perfusion AB (publ)
Swedish 108.6 KB
2025-01-28 07:30
Earnings Release
Swedish 1.2 MB
2025-01-28 07:30
Annual / Quarterly Financial Statement
English 1.2 MB
2024-12-02 10:46
Major Shareholding Notification
Swedish 8.3 KB
2024-10-24 07:30
Quarterly Report
Swedish 1.2 MB

Automate Your Workflow. Get a real-time feed of all Xvivo Perfusion filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Xvivo Perfusion via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-04-28 Lena Hagman Other Buy 1,500 466,500.00 SEK
2024-11-25 Christoffer Björn Rosenblad Other Sell 2,000 915,000.00 SEK
2024-02-29 Kristoffer Nordström Other Buy 335 88,440.00 SEK
2023-11-14 Gösta Johannesson Other Buy 500 124,500.00 SEK
2023-04-24 Lars Henriksson Other Buy 400 107,200.00 SEK
2022-11-02 Gösta Johannesson Other Buy 200 34,000.00 SEK
2022-11-01 Gösta Johannesson Other Buy 1,000 166,500.00 SEK
2022-08-19 Dag Andersson Tilk Other Buy 499 99,700.20 SEK
2022-05-24 Dag Andersson Tilk Other Other 5,417 1,115,251.96 SEK
2022-05-24 Christoffer Björn Rosenblad Other Other 2,708 557,523.04 SEK

Peer Companies

Company Country Ticker View
3-D Matrix,Ltd. Logo
Develops peptide-based medical devices for surgical bleeding control and wound healing.
Japan 7777
aap Implantate AG Logo
Develops and markets orthopedic trauma implants and plating systems for fracture treatment globally.
Germany AAQ1
ABL Diagnostics Logo
Develops integrated diagnostic solutions for infectious diseases for labs, clinicians, & researchers.
France ABLD
ADVANCED MEDICAL SOLUTIONS GROUP PLC Logo
Develops and manufactures innovative tissue-healing technologies for wound care and surgery.
United Kingdom AMS
Affluent Medical Logo
Developing minimally invasive, restorative implants for structural heart disease and urology.
France AFME
AIOBIO Co., Ltd. Logo
Develops AI biofluorescence dental tools for early detection of caries and plaque.
South Korea 447690
Airway Medix S.A. Logo
Develops single-use devices for mechanically ventilated patients in ICUs and anesthesiology.
Poland AWM
Alcon AG Logo
Global leader in eye care, offering surgical equipment, contact lenses, and ocular health products.
Switzerland ALC
Aligned Genetics, Inc. Logo
Develops advanced equipment for cell imaging and diagnostics for research & medicine.
South Korea 238120
Allmed Solutions Ltd. Logo
Develops, manufactures, and markets minimally invasive medical devices and solutions globally.
Israel ALMD

Talk to a Data Expert

Have a question? We'll get back to you promptly.